Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2.
Pooja SrivastavaMegan L ZillaRana NaousDaniel MarkerPooria KhoshnoodiMelissa BurgessArmando HerraduraJinhua WuLea F SurreyIvy JohnPublished in: Histopathology (2023)
We expand the genetic spectrum of OFMTs with two novel gene fusions, PHF1::FOXR1 and PHF1::FOXR2. These cases confirm the previously reported tendencies for OFMTs with rare variant fusions to demonstrate malignant behavior, unusual morphology, and non-specific immunophenotype.